About Endra Life Sciences
Endra Life Sciences is a company based in Ann Arbor (United States) founded in 2007.. Endra Life Sciences has raised $287.1 thousand across 5 funding rounds. The company has 21 employees as of December 31, 2024. Endra Life Sciences offers products and services including TAEUS®.
- Headquarter Ann Arbor, United States
- Employees 21 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Endra Life Sciences Inc.
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-11.51 M-14.39as on Dec 31, 2024
-
EBITDA
$-17.93 M-75.05as on Dec 31, 2024
-
Total Equity Funding
$287.1 K (USD)
in 5 rounds
-
Latest Funding Round
$14.4 M (USD), Post-IPO
Oct 10, 2025
-
Investors
-
Employee Count
21
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Endra Life Sciences
Endra Life Sciences is a publicly listed company on the NASDAQ with ticker symbol NDRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Endra Life Sciences
Endra Life Sciences offers a comprehensive portfolio of products and services, including TAEUS®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Non-invasive ultrasound tool for measuring liver fat and detecting disease.
Unlock access to complete
Unlock access to complete
Funding Insights of Endra Life Sciences
Endra Life Sciences has successfully raised a total of $287.1K across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $14.4 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Post-IPO — $14.4M
-
First Round
First Round
(25 Mar 2014)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - Endra Life Sciences | Valuation |
investors |
|
| Dec, 2019 | Amount | Post-IPO - Endra Life Sciences | Valuation |
investors |
|
| Jul, 2019 | Amount | Post-IPO - Endra Life Sciences | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Endra Life Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Endra Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Endra Life Sciences Comparisons
Competitors of Endra Life Sciences
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Endra Life Sciences
Frequently Asked Questions about Endra Life Sciences
When was Endra Life Sciences founded?
Endra Life Sciences was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Where is Endra Life Sciences located?
Endra Life Sciences is headquartered in Ann Arbor, United States. It is registered at Ann Arbor, Michigan, United States.
Who is the current CEO of Endra Life Sciences?
Francois Michelon is the current CEO of Endra Life Sciences.
Is Endra Life Sciences a funded company?
Endra Life Sciences is a funded company, having raised a total of $287.1K across 5 funding rounds to date. The company's 1st funding round was a Post-IPO of $2.81M, raised on Mar 25, 2014.
How many employees does Endra Life Sciences have?
As of Dec 31, 2024, the latest employee count at Endra Life Sciences is 21.
What does Endra Life Sciences do?
Developer of ultrasound imaging technology for liver disease detection. The company offers Thermo-acoustic enhanced ultrasound (TAEUS) that uses radio frequency and ultrasound waves for deep tissue imaging and to measure fat in the liver which is the cause of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH).
What products or services does Endra Life Sciences offer?
Endra Life Sciences offers TAEUS®.
Is Endra Life Sciences publicly traded?
Yes, Endra Life Sciences is publicly traded on NASDAQ under the ticker symbol NDRA.
What is Endra Life Sciences's ticker symbol?
The ticker symbol of Endra Life Sciences is NDRA on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.